Key result
Tissue-type plasminogen activator promotes the disaggregation of human platelets in plasma through kinetically selective proteolysis of cohesive fibrinogen by plasmin.
Why the study?
Does tissue-type plasminogen activator (t-PA) promote disaggregation of human platelets in plasma?
Does tissue-type plasminogen activator (t-PA) promote disaggregation of human platelets in plasma?
t-PA facilitates platelet disaggregation in plasma via plasmin-mediated proteolysis of cohesive fibrinogen, a process significantly potentiated by aspirin.
t-PA may aid platelet disaggregation in plasma; hypothesis-generating for human thrombolysis and requires clinical validation.
We studied the disaggregation of human platelets by tissue-type plasminogen activator (t-PA). When added to a suspension of human platelets induced to aggregate in plasma with adenosine 5'-diphosphate, t-PA promoted disaggregation of platelets over several minutes. Addition of fresh plasma or purified human fibrinogen to disaggregated platelets facilitated (reversible) aggregation and subsequent disaggregation. Aspirin treatment of platelets markedly potentiated the ability of t-PA to induce disaggregation. Disaggregation was inhibited by alpha-2-antiplasmin. Comparative analysis of the rate of proteolysis of platelet-bound fibrinogen with that of ambient plasma fibrinogen suggested that fibrinogenolysis of cohesive fibrinogen occurred more rapidly than fibrinogenolysis of ambient fibrinogen. These data demonstrate that t-PA facilitates platelet disaggregation in plasma through kinetically selective proteolysis of cohesive fibrinogen by plasmin, and suggest that thrombolytic mechanisms may serve both to remove platelets from platelet-fibrin thrombi and to disperse circulating platelet aggregates.
No takes yet. Share an insight, caveat, or question.
Loscalzo et al. (1987) studied In vitro platelet aggregation. Tissue-type plasminogen activator (t-PA) vs. Control (no t-PA) was evaluated on Platelet disaggregation. Tissue-type plasminogen activator promotes the disaggregation of human platelets in plasma through kinetically selective proteolysis of cohesive fibrinogen by plasmin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: